Introduction

100
Snake envenoming is one of the world's most lethal neglected tropical diseases, systemic coagulopathy and/or haemorrhage, while hypopituitarism has also been reported [7] .
118
In addition, D. siamensis venom can induce renal toxic effects (nephrotoxicity), which are 119 characterized by hematuria, tubular necrosis and acute renal failure [8] . These variable 120 clinical signs observed following snakebites are a consequence of Russell's viper venoms 121 exhibiting considerable variation across their range, resulting in differences in their toxin 122 profiles, which in turn impacts upon clinical outcomes observed in snakebite victims [9] .
123
Two major snake venom toxin families are thought to be predominately responsible 124 for the bleeding disorders and renal failure observed following systemic envenoming by D. 125 siamensis, the enzymatic phospholipases A 2 (PLA 2 ) and snake venom metalloproteinases 126 (SVMP). Both toxin types are often found to be major components of viper venoms [10] , but 127 each toxin family is known to encode multiple isoforms that vary among species and are 128 capable of exhibiting distinct functional activities [10, 11] . Such protein neo-/sub-129 functionalization is thought to be underpinned by multiple gene duplication events coupled to 130 accelerated bursts of adaptive evolution [12] [13] [14] . Consequently, snake venom PLA 2 s are The only effective treatment for systemic snakebite envenoming is specific 150 antivenom, which consists of polyclonal antibodies isolated from hyperimmune animal 151 serum/plasma. Non-pharmacological treatments, which include the local use of tourniquets, 152 cross-shaped skin incision, local suction or irrigation, or the administration of non-specific 153 snake antivenom (i.e. made against snake species other than that which bit the patient) are 154 typically ineffective, and potentially harmful [22] . There are two types of specific antivenom 
Relative avidity ELISA.
262
The chaotropic ELISA assay was performed as previously described [26] . In brief, the 
In vitro coagulopathic activity
288
The neutralising effect of Thai antivenoms on the coagulopathic activity of D.
289
siamensis venoms was determined using a previously described citrated bovine plasma 290 coagulation assay [27] . Briefly, frozen bovine plasma (VWR International, Leicestershire, 291 UK) was defrosted at 37 C and centrifuged to remove precipitates (20-30 s at 1400 rpm). at two (i.e. 0.7 mL for 300 g rat) and three times (i.e. 1.05 mL for 300 g rat) the were measuring using 340 and 383 nm wavelengths by bichromatic rate, whereas plasma 358 creatinine level was measured using 540 and 700 nm wavelengths using bichromatic rate. 
Data Analysis and Statistics
360
Increases in plasma BUN and creatinine were calculated by subtracting the values of 361 the control group from the treatment group, and then presented as mean ± standard error of 362 the mean (SEM). The 95% confidence interval (95% CI) was also calculated. All statistical 363 analyses were performed using GraphPad Prism 6 (GraphPad Software Inc., USA). Multiple 13 364 comparisons were made using one-way analysis of variance (ANOVA) followed by 365 Bonferroni's multiple comparison test. Statistical significance was indicated where P < 0.05. Table 1 .
379
The general trend, including at this dilution, revealed that the antibody-venom binding levels Figure 3 , Table 2 ). The avidity of Table 2 ). weight range in each sample ( Figure 4A ). There is, however, a degree of variation in the toxic 448 constituents observed, both in terms of the intensity of shared venom components, and the 449 unique presence of protein bands in some instances ( Figure 4A ). Notably, a high degree of Taiwan. The antivenoms were tested at the manufacturer's recommended therapeutic dose.
Quantifying the coagulopathic venom effects and their neutralization by antivenom
513
The data represents kinetic profiles of clotting from the plasma coagulation assay displayed venom alone (n = 4-5, P < 0.05, one-way ANOVA, followed by Bonferroni's t-test, Figure   532 6B).
533
In addition to BUN, the intramuscular administration of D. siamensis venom (700 534 µg/kg) also resulted in significant increases in plasma creatinine levels compared to the 535 control group (Figure 7A and B). Creatinine levels also increased over time and were 536 significantly reduced when DSAV at 3× the recommended therapeutic dose (n = 4-5, P < 537 0.05) was intravenously administration prior to the injection of venom, but no significant 538 effect was observed when 2× the recommended dose was administered ( Figure 7A ).
539
However, in contrast with BUN, the administration of antivenom (i.v., infusion; 3× 540 recommended titre) 1 h after the i.m. administration of venom caused a significant decrease 541 in plasma creatinine compared to the administration of venom alone (n = 4-5, P < 0.05, one-542 way ANOVA, followed by Bonferroni's t-test, Figure 7B ). 
596
We first used a range of immunological assays to assess the amount of binding, end, further work is needed to assess the neutralising effect of antivenom against
